Upcoming Quarterly

Hi All,

Here is the latest update of my graphs with the figures quoted from the last Morgan video presentation. Please note the following.

© The numbers quoted at the presentations are not what I consider to be official numbers from AHZ. Therefore they   should be used as only as a guide. They will be adjusted accordingly as more information comes to hand.

© The total number of centres world wide does not include the 3 centres in Australia. I will add those in the next update that I do.

© We still have no info on the number of Canadian and Hong centres re-ordering CardioCel. I hoping to see news on these in the upcoming March quarterly report

© If there are any other graphs that you would like to see with the information that is available to hand then let me know and I see what I can do.


----------------------------------------------------------------------------------------------------------------------------------------------










Share Price Catalysts - Taken from the latest Proactive Investors article

Immunotherapies
- Completion of HSV-2 Phase II enrolment (end 2Q2015);
- Interim Analysis from study (4Q2015); and
- Starting Phase I study for Human Papilloma Virus vaccine.

Regenerative tissue portfolio and CardioCel®
- Increase number of centres using CardioCel® globally;
- Growing sales in the US, Asia & Europe;
- Additional market approvals for CardioCel® in Asian markets;
- Initiation of CardioCel® market expansion studies such as a Tri-leaflet Aortic Heart Valve Repair Study;
- Progress on use of ADAPT® treated tissue in the repair of dura mater, the outer membrane enveloping the brain and spinal cord; and
- Expanded regenerative tissue portfolio.


Haplo